{"id":"https://openalex.org/W2013523985","doi":"https://doi.org/10.1517/13543784.2013.812631","title":"Current status of renin\u2013aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease","display_name":"Current status of renin\u2013aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease","alternate_titles":[],"publication_year":2013,"publication_date":"2013-06-26","ids":{"openalex":"https://openalex.org/W2013523985","doi":"https://doi.org/10.1517/13543784.2013.812631","mag":"2013523985","pmid":"https://pubmed.ncbi.nlm.nih.gov/23800077"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.2013.812631","doi":"https://doi.org/10.1517/13543784.2013.812631","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2013.812631","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2013523985"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061574701","display_name":"Emma L. Ashby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800201669","display_name":"Frenchay Hospital","ror":"https://ror.org/03z8x2j90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201669","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emma Louise Ashby","raw_affiliation_strings":["University of Bristol, Frenchay Hospital, School of Clinical Sciences, John James Laboratories, Dementia Research Group , Bristol, BS16 1LE , UK Patrick.Kehoe@bristol.ac.uk","Bristol Medical School (THS)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bristol, Frenchay Hospital, School of Clinical Sciences, John James Laboratories, Dementia Research Group , Bristol, BS16 1LE , UK Patrick.Kehoe@bristol.ac.uk","institution_ids":["https://openalex.org/I2800201669","https://openalex.org/I36234482"]},{"raw_affiliation_string":"Bristol Medical School (THS)","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027119794","display_name":"Patrick G. Kehoe","orcid":"https://orcid.org/0000-0002-7542-1139","observed_orcids":["https://orcid.org/0000-0002-7542-1139"]},"institutions":[{"id":"https://openalex.org/I2800201669","display_name":"Frenchay Hospital","ror":"https://ror.org/03z8x2j90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201669","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrick G Kehoe","raw_affiliation_strings":["University of Bristol, Frenchay Hospital, School of Clinical Sciences, John James Laboratories, Dementia Research Group, Bristol, BS16 1LE, UK Patrick.Kehoe@bristol.ac.uk","Bristol Neuroscience"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bristol, Frenchay Hospital, School of Clinical Sciences, John James Laboratories, Dementia Research Group, Bristol, BS16 1LE, UK Patrick.Kehoe@bristol.ac.uk","institution_ids":["https://openalex.org/I2800201669","https://openalex.org/I36234482"]},{"raw_affiliation_string":"Bristol Neuroscience","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.136,"has_fulltext":false,"cited_by_count":58,"citation_normalized_percentile":{"value":0.74813711,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"22","issue":"10","first_page":"1229","last_page":"1242"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.6234999895095825,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.6234999895095825,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.20399999618530273,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.15160000324249268,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9890000224113464},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.4909999966621399},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9490000009536743},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":1.0},{"id":"https://openalex.org/keywords/renin-inhibitors","display_name":"renin inhibitors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cerebral-blood-flow","display_name":"cerebral blood flow","score":0.6710000038146973},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.7160000205039978},{"id":"https://openalex.org/keywords/central-nervous-system","display_name":"central nervous system","score":0.6990000009536743},{"id":"https://openalex.org/keywords/dementia","display_name":"dementia","score":0.5799999833106995},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7399444580078125},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.6613677740097046},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6173452138900757},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.5722643733024597},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4977577030658722},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.4616279900074005},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.4505945146083832},{"id":"https://openalex.org/C2910553456","wikidata":"https://www.wikidata.org/wiki/Q285044","display_name":"Angiotensin Receptor Blockers","level":4,"score":0.41755443811416626},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.34620988368988037},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2768436670303345},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.19903934001922607},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10660490393638611}],"mesh":[{"descriptor_ui":"D000092502","descriptor_name":"Renin Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002560","descriptor_name":"Cerebrovascular Circulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1517/13543784.2013.812631","doi":"https://doi.org/10.1517/13543784.2013.812631","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2013.812631","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:23800077","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23800077","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire_cris_publications/d17ba7b6-4224-4c2b-bc5a-6717237da2de","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/1983/d17ba7b6-4224-4c2b-bc5a-6717237da2de","pdf_url":null,"source":{"id":"https://openalex.org/S7407055359","display_name":"Explore Bristol Research","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ashby, E L & Kehoe, P G 2013, 'Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease', Expert Opinion on Investigational Drugs, vol. 22, no. 10, pp. 1229-1242. https://doi.org/10.1517/13543784.2013.812631","raw_type":"info:eu-repo/semantics/review"},{"id":"pmh:oai:research-information.bris.ac.uk:publications/d17ba7b6-4224-4c2b-bc5a-6717237da2de","doi":null,"is_oa":false,"landing_page_url":"https://research-information.bris.ac.uk/en/publications/d17ba7b6-4224-4c2b-bc5a-6717237da2de","pdf_url":null,"source":{"id":"https://openalex.org/S4306400895","display_name":"Bristol Research (University of Bristol)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I36234482","host_organization_name":"University of Bristol","host_organization_lineage":["https://openalex.org/I36234482"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ashby, E L & Kehoe, P G 2013, 'Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease', Expert Opinion on Investigational Drugs, vol. 22, no. 10, pp. 1229-1242. https://doi.org/10.1517/13543784.2013.812631","raw_type":"info:eu-repo/semantics/review"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":95,"referenced_works":["https://openalex.org/W188361278","https://openalex.org/W1552526595","https://openalex.org/W1554181954","https://openalex.org/W1563379451","https://openalex.org/W1569630040","https://openalex.org/W1575225446","https://openalex.org/W1576419152","https://openalex.org/W1586213696","https://openalex.org/W1590062989","https://openalex.org/W1597238539","https://openalex.org/W1604413671","https://openalex.org/W1653750413","https://openalex.org/W1697077861","https://openalex.org/W1729585270","https://openalex.org/W1785942725","https://openalex.org/W1828947725","https://openalex.org/W1835154286","https://openalex.org/W1895881996","https://openalex.org/W1967645451","https://openalex.org/W1969501720","https://openalex.org/W1977665419","https://openalex.org/W1978998472","https://openalex.org/W1981132320","https://openalex.org/W1985625400","https://openalex.org/W1993369637","https://openalex.org/W1994344429","https://openalex.org/W1995817686","https://openalex.org/W1996319118","https://openalex.org/W1998959104","https://openalex.org/W1999061258","https://openalex.org/W2000087476","https://openalex.org/W2000362399","https://openalex.org/W2000781871","https://openalex.org/W2002254893","https://openalex.org/W2024757236","https://openalex.org/W2026771136","https://openalex.org/W2027130344","https://openalex.org/W2036792490","https://openalex.org/W2037581474","https://openalex.org/W2039546317","https://openalex.org/W2039857463","https://openalex.org/W2040079480","https://openalex.org/W2043583692","https://openalex.org/W2044555983","https://openalex.org/W2047844622","https://openalex.org/W2048981378","https://openalex.org/W2053431736","https://openalex.org/W2054985387","https://openalex.org/W2060200294","https://openalex.org/W2062720767","https://openalex.org/W2064623974","https://openalex.org/W2067203120","https://openalex.org/W2067432590","https://openalex.org/W2069140826","https://openalex.org/W2069155331","https://openalex.org/W2071068165","https://openalex.org/W2071762923","https://openalex.org/W2075345905","https://openalex.org/W2076325467","https://openalex.org/W2077595053","https://openalex.org/W2080162788","https://openalex.org/W2083985618","https://openalex.org/W2084899590","https://openalex.org/W2085176275","https://openalex.org/W2095260656","https://openalex.org/W2097957153","https://openalex.org/W2098429613","https://openalex.org/W2098900970","https://openalex.org/W2100135916","https://openalex.org/W2101348366","https://openalex.org/W2104565625","https://openalex.org/W2106122924","https://openalex.org/W2118008234","https://openalex.org/W2118729903","https://openalex.org/W2120175510","https://openalex.org/W2123779772","https://openalex.org/W2129267808","https://openalex.org/W2134673986","https://openalex.org/W2141176548","https://openalex.org/W2142090603","https://openalex.org/W2143119713","https://openalex.org/W2144859988","https://openalex.org/W2145875145","https://openalex.org/W2158427090","https://openalex.org/W2162069510","https://openalex.org/W2164444293","https://openalex.org/W2165146299","https://openalex.org/W2165336346","https://openalex.org/W2166105345","https://openalex.org/W2168610437","https://openalex.org/W2169731574","https://openalex.org/W2171418514","https://openalex.org/W2171645631","https://openalex.org/W2335530968","https://openalex.org/W4249454396"],"related_works":["https://openalex.org/W1597238539","https://openalex.org/W2171192373","https://openalex.org/W3045199331","https://openalex.org/W1966621863","https://openalex.org/W2377804669","https://openalex.org/W2792021977","https://openalex.org/W2128387720","https://openalex.org/W1978290642","https://openalex.org/W2997108126","https://openalex.org/W4405329253"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Hypertension":[1],"is":[2,38,45,173],"a":[3,39,125],"modifiable":[4,42],"risk":[5],"factor":[6],"for":[7,60,108],"Alzheimer's":[8],"disease":[9],"(AD)":[10],"and":[11,73,85,99,130],"other":[12],"dementias.":[13],"Yet,":[14],"despite":[15],"this":[16,30],"well-documented":[17],"association,":[18],"few":[19],"of":[20,55,62,79,93,97,120,141,156,165],"the":[21,118,138,147,157],"current":[22,166],"strategies":[23],"to":[24,89,127,134,176],"treat":[25,128],"AD":[26,129],"are":[27,58,81],"directed":[28],"at":[29],"possible":[31],"target.":[32],"The":[33],"renin-aldosterone":[34],"angiotensin":[35,68,143],"system":[36],"(RAAS)":[37],"centrally":[40],"active":[41],"pathway":[43,159],"that":[44],"involved":[46],"in":[47,146,160,169,181],"cerebral":[48],"blood":[49],"flow":[50],"regulation.":[51],"Currently,":[52],"three":[53],"classes":[54],"RAAS-targeting":[56,122],"drugs":[57,123,168],"licensed":[59],"treatment":[61],"peripheral":[63],"hypertension--angiotensin-converting":[64],"enzyme":[65],"inhibitors":[66,76],"(ACE-Is),":[67],"II":[69],"receptor":[70],"blockers":[71],"(ARBs)":[72],"direct":[74],"renin":[75],"(DRIs).":[77],"All":[78],"these":[80],"generally":[82],"well":[83],"tolerated":[84],"have":[86],"been":[87],"shown":[88],"offer":[90],"varying":[91],"degrees":[92],"protection":[94],"on":[95],"aspects":[96,133],"cognition":[98],"dementia,":[100],"thus":[101],"making":[102],"them":[103],"an":[104],"attractive":[105],"therapeutic":[106,179],"option":[107],"AD.":[109,182],"AREAS":[110],"COVERED:":[111],"This":[112],"review":[113],"summarises":[114],"existing":[115],"evidence":[116],"regarding":[117],"plausibility":[119],"using":[121],"as":[124],"strategy":[126],"highlights":[131],"unresolved":[132],"such":[135],"approaches,":[136],"namely":[137],"potential":[139],"impact":[140],"altering":[142],"II-mediated":[144],"processes":[145],"central":[148],"nervous":[149],"system.":[150],"EXPERT":[151],"OPINION:":[152],"Continued":[153],"biochemical":[154],"research":[155],"RAAS":[158],"combination":[161],"with":[162],"formal":[163],"investigation":[164],"RAAS-modifying":[167],"randomised":[170],"clinical":[171],"trials":[172],"now":[174],"necessary":[175],"determine":[177],"their":[178],"value":[180]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2013523985","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
